Roux-en-Y gastric bypass, a type of weight-loss surgery, kept type 2 diabetes in remission for up to 15 years and most of the weight off for up to 20 years in one of the largest long-term studies of patients undergoing the procedure.
Vertex’s stock hurt after non-opioid pain drug shows benefit similar to placebo
The company’s stock has dropped by 15% after the Phase II trial data was announced. Image credit: Shutterstock / pathdoc Vertex Pharmaceuticals’s non-opioid-based pain therapy
December 21, 2024